Oestrogen receptor: a stable phenotype in breast cancer (original) (raw)

British Journal of Cancer volume 73, pages 5–12 (1996)Cite this article

Abstract

Oestrogen receptor (ER) expression in breast cancer is regarded as a phenotype that may change during the natural history of the disease or during endocrine therapy. It has been suggested that in up to 70% of tumours that show acquired resistance the mechanism may be changed in ER status from positive to negative. This paper proposes an alternative hypothesis that ER expression in a stable phenotype in breast cancer. The paper reviews the literature on ER expression during the natural history of breast cancer in patients and also presents data on the effect of endocrine therapy on ER expression. If the alternative hypothesis is true it has important implications for treatment from chemoprevention to acquired endocrine resistance in advanced disease. Equally, if the hypothesis is true, attempts to develop laboratory models of endocrine resistance where ER-positive tumours become ER negative need to be re-evaluated.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 24 print issues and online access

$259.00 per year

only $10.79 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. City Hospital, Nottingham, UK
    JFR Robertson

Rights and permissions

About this article

Cite this article

Robertson, J. Oestrogen receptor: a stable phenotype in breast cancer.Br J Cancer 73, 5–12 (1996). https://doi.org/10.1038/bjc.1996.2

Download citation

This article is cited by